| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |